Idorsia Aktie

2,80CHF 0,01CHF 0,36%
Idorsia für 0 Euro bei ZERO ordern (zzgl. Spreads)

WKN DE: A2DTEB / ISIN: CH0363463438

<
Kurse + Charts + Realtime
Kurs + Chart
Times + Sales
Börsenplätze
Historisch
>
<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>

Personal

2020 2021 2022 2023 2024
Personal am Ende des Jahres 0 0 0 0 0
Umsatz pro Mitarbeiter in Mio. EUR 0,00 0,00 0,00 0,00 0,00

Bilanz (in Mio. CHF) - Aktiva

2020 2021 2022 2023 2024
Summe Umlaufvermögen 1 035 1 077 596 276 255
Summe Anlagevermögen 401 405 308 224 250
Summe Aktiva 1 435 1 483 904 500 506

Bilanz (in Mio. CHF) - Passiva

2020 2021 2022 2023 2024
Summe Fremdkapital 850 1 379 1 565 1 469 1 718
Summe Eigenkapital 585 104 -661 -969 -1 212
Summe Passiva 1 435 1 483 904 500 506

Adresse

Hegenheimermattweg 91, 4123 Allschwil
Telefon +41 (58) 844-10-10
Internet http://www.idorsia.com

Management

Alberto Gimona
Head-Global Clinical Development & Executive VP
Andrew Jones
SVP, Head-Corporate Communications & IR
Antonio Olivieri
Chief Medical Officer & Head-Global Medical Affair
Arno Groenewoud
Chief Financial Officer & Executive Vice President
Bart Filius
Non-Executive Director
Gaby Scherer
Senior VP & Head-Global Human Resources
Jean-Paul Clozel
Chairman
Julien Gander
Chief Legal & Corporate Development Officer, EVP
Martine Clozel
Chief Scientific Officer, EVP & Head-Research
Mathieu Simon
Vice Chairman
Olivier Lambert
Senior Vice President & Head-Technical Operations
Sandesh Mahatme
Non-Executive Director
Srishti Gupta
Chief Executive Officer & Director